TheMarketingblog

Optrex invests £1.6m in a new ‘blinking great’ promotional campaign

May 2015:  A new advertisement campaign from RB’s leading eye care brand Optrex  breaks this week.

With Dry Eye a growing problem, currently representing 55% of the eye care market, the new campaign has been developed to promote awareness of dry eye – its causes, effects and the benefits of using Optrex Actimist 2in1 Eye Spray as a convenient and easy to use solution.

The campaign which broke on the 13th May and will run until beginning of August 2015 will feature on television and digital platforms which will target those consumers at greatest risk of Dry Eye.

The impactful creative uses the eye’s perspective to show the damage caused by everyday modern life on the eye’s protective layer. It focuses on a close up of an eye in which we can see the reflection of a computer screen and we hear the keyboard typing.  Dryness starts to spread like a layer across the eye like on an old painting.  The ad develops to demonstrate how Optrex Actimist 2in1 Eye Spray can be sprayed over the closed eyelid to help repair the protective layer.

Clinically proven, Optrex Actimist 2in1 Eye Spray contains liposomes which when sprayed on closed eyes collect at the eye lid. Following blinking, the liposomes are spread over the eye to help repair the moisture barrier to reduce moisture loss.  It takes seconds to use, can be used over make up, as it won’t smudge, is suitable for use with contact lenses and provides up to 4 hours relief*.   Each bottle contains up to 100 applications and there is no need to throw the bottle away after 28 days (like many other treatments) as it can be used for up to six months after first opening.

The range:

Optrex ActiMist 2in1 Eye Spray for dry + irritated eyes 10ml

Other variants also available:

Optrex ActiMist 2in1 Eye Spray for itchy + watery eyes 10ml

Optrex ActiMist 2in1 Eye Spray for tired + uncomfortable eyes 10ml

 

* Dry and irritated eyes due to the disturbed lipid layer of the tear film, approx. 80% of dry eye cases.